The first in-depth global analysis of antimicrobial resistance (AMR) forecasts over 39 million deaths from infections by 2050 ...

The researchers estimated that, in 2050, the number of global deaths attributable to antimicrobial resistance could reach 1.9 ...

Potential for the development of antimicrobial resistance with sulopenem, as well as closely related carbapenems, was a major ...

By 2050, around 2 million people — the majority aged over 70 — could die from drug-resistant infections each year.

"Is it safe to hit a kid in the head 200 times?" -- Chris Nowinski, PhD, of the Concussion Legacy Foundation in Boston, on ...

The number of lives lost around the world due to infections that are resistant to the medications intended to treat them ...

China: In a significant advancement for managing urolithiasis patients with urinary tract infections caused by ESBL-producing ...

SALT LAKE CITY — Drug resistant superbugs could kill more than 39 million people by 2050, according to a new study. Deaths ...

baumannii and other Enterobacteriaceae. There are some data available indicating that combination therapy containing a carbapenem drug is associated with improved outcomes in the treatment of CR K.

Bacterial pneumonia and sepsis are leading causes of hospitalization and death. Researchers in Kansas State University's ...

Comprehensive study estimates the global antimicrobial resistance (AMR) burden from 1990 to 2021, identifying significant age ...

The Infectious Diseases Society of America (IDSA) 2024 guidance on the treatment of AMR gram-negative infections has been published.